
09/01/2025
The FDA’s new COVID-19 vaccine rules limit eligibility to those 65+ or with certain health risks—shifting away from universal access.
For public health communicators, this change may spark confusion and raise new challenges in messaging, especially as communities prepare for winter surges.
Staying ahead of the narrative will be key in helping the public understand evolving guidance. 💉
https://www.npr.org/sections/shots-health-news/2025/08/27/nx-s1-5515503/fda-covid-vaccines-restricted
The Food and Drug Administration approved the next round of COVID-19 vaccines, but is restricting them to people at high risk for COVID complications.